Excitotoxicity and its role in neurological diseases

Excitotoxicity is a pathological process that occurs when neurons are damaged and destroyed due to overstimulation of excitatory neurotransmitter receptors, particularly glutamate receptors. This phenomenon is associated with a variety of neurological and neurodegenerative disorders, such as stroke, Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease. Excitotoxicity is considered a key mechanism in neuronal damage, and its understanding is crucial for the development of neuroprotective therapeutic strategies.

What is Excitotoxicity?

Excitotoxicity is a phenomenon that occurs when levels of excitatory neurotransmitters, mainly glutamate, become excessive in the central nervous system. Glutamate, which is normally essential for functions such as learning and memory, can become harmful if it accumulates in large amounts. Excess glutamate leads to overstimulation of N-methyl-D-aspartate (NMDA) receptors and other glutamate receptors, causing a massive influx of calcium ions into neurons. This uncontrolled calcium flow triggers a cascade of harmful events, including the activation of destructive enzymes and the generation of free radicals, ultimately resulting in cell death.

This mechanism has been linked to a series of pathological events, both acute and chronic, including brain trauma, cerebral ischemia, and progressive neurodegenerative disorders.

Mechanisms of Excitotoxicity

The process of excitotoxicity involves a series of complex biochemical events that ultimately result in neuronal dysfunction and death. Some of the key mechanisms include:

1. Overstimulation of glutamate receptors: Glutamate is the main excitatory neurotransmitter in the central nervous system. When its levels are elevated, receptors such as NMDA and AMPA become excessively activated, allowing an abnormally high influx of calcium and sodium ions into neurons.
2. Intracellular calcium overload: Calcium is crucial for normal neuronal function, but its excess can activate several destructive enzymes, such as proteases, lipases, and endonucleases, which cause structural damage to neuronal proteins, membrane lipids, and DNA.
3. Oxidative stress: Excess calcium also contributes to the formation of reactive oxygen species (ROS) and nitrogen species, which damage cells through a process known as oxidative stress. These molecules can harm cell membranes, mitochondria, and other cellular structures.
4. Mitochondrial dysfunction: Calcium overload also negatively affects mitochondria, the energy powerhouses of the cells, leading to inadequate energy production and the release of pro-apoptotic factors (inducers of programmed cell death). Mitochondrial dysfunction is a key event in the progression of excitotoxicity.
5. Activation of apoptosis and necrosis: Neurons subjected to excitotoxicity can die through both necrosis (an uncontrolled form of cell death that results in cell rupture and inflammation) and apoptosis (a more controlled process of programmed cell death). Excitotoxicity often triggers both forms of cell death, depending on the severity of the damage.

Excitotoxicity in Neurological Diseases

Excitotoxicity is a common factor in a wide range of neurological diseases and disorders. Below are some of the clinical contexts where this phenomenon plays a crucial role:

1. Stroke: During a stroke, the reduction of blood flow to the brain causes oxygen and glucose deprivation, leading to massive glutamate release into the extracellular space. This excess glutamate triggers excitotoxicity in the affected regions, exacerbating brain damage. Early intervention to reduce excitotoxicity can be critical in minimizing damage after a stroke.
2. Traumatic Brain Injury (TBI): Following a traumatic brain injury, glutamate levels increase due to neuronal damage. Excitotoxicity contributes to secondary brain injury, worsening inflammation and long-term neuronal degeneration. Neuroprotective therapies that inhibit NMDA receptors are being investigated to limit the impact of this phenomenon.
3. Neurodegenerative Diseases: In conditions such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), chronic excitotoxicity can accelerate neuronal degeneration. In Alzheimer’s disease, for example, glutamate receptor dysfunction due to the accumulation of beta-amyloid plaques exacerbates excitotoxicity. Treatments that modulate glutamate activity are an active area of research in these diseases.
4. Multiple Sclerosis (MS): Excitotoxicity also plays a role in multiple sclerosis, an autoimmune disease that affects myelin in the central nervous system. Chronic inflammation and damage to oligodendrocytes can trigger glutamate release and cause axonal damage due to excitotoxicity.
5. Epilepsy: In patients with epilepsy, recurrent seizures can lead to excessive glutamate release, contributing to excitotoxic neuronal damage. Controlling glutamate release is a key approach in seizure treatment to prevent progressive neurological deterioration.

Therapeutic interventions in Excitotoxicity

The treatment of excitotoxicity has been a key objective in the development of neuroprotective therapies for a variety of neurological conditions. Some of the strategies currently under investigation include:

1. NMDA receptor antagonists: These drugs block the activity of NMDA receptors, which are the main mediators of excitotoxicity. Examples of NMDA antagonists include memantine, used in the treatment of Alzheimer’s disease, and others currently in clinical trials for stroke and TBI. However, prolonged use of these antagonists can have significant side effects, so careful balance is required.
2. Antioxidants: Since oxidative stress plays an important role in excitotoxicity, antioxidants can help mitigate cellular damage. Antioxidant compounds such as vitamin E and lipoic acid are being studied for use in various neurological conditions.
3. Modulation of glutamate activity: Inhibitors of glutamate release or modulators of its reuptake can help reduce extracellular glutamate levels and prevent excitotoxicity. Examples of modulators include riluzole, used in ALS, which works by inhibiting glutamate release.
4. Brain cooling (therapeutic hypothermia): Therapeutic hypothermia has been shown to be effective in reducing excitotoxic damage in situations of cerebral ischemia, such as stroke. By lowering brain temperature, metabolic demand and glutamate release are reduced, thereby limiting neuronal damage.
5. Neurotrophic factors: These growth factors help protect and repair neurons against excitotoxic damage. Brain-derived neurotrophic factor (BDNF) and other similar factors are being investigated for their therapeutic potential in diseases such as Alzheimer’s and Parkinson’s.

Future perspectives in Excitotoxicity research

The understanding of excitotoxicity mechanisms has led to the development of several promising therapeutic strategies, although many treatments are still in experimental stages. Future perspectives include:

• Personalized therapies: With the advancement of precision medicine, treatments for excitotoxicity could be tailored to the individual genetic and molecular characteristics of patients.
• Combined therapies: The combination of NMDA antagonists with antioxidants and other drugs could provide greater protection against excitotoxicity in situations of acute and chronic neurological damage.
• Gene therapies: Genetic manipulation to reduce the expression of glutamate receptors or increase the production of neurotrophic factors may become a viable strategy to prevent long-term excitotoxic damage.

In conclusion, excitotoxicity is a complex phenomenon that plays a crucial role in neuronal damage associated with a variety of neurological diseases. Advances in biomedical research are bringing us closer to effective therapies that can mitigate or prevent excitotoxic damage, offering new hope for patients with debilitating neurological disorders.

If you would like more information about NeuroAiD II, please fill out this contact form.